Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Elite Pharma Inc (ELTP)

Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 408,614
  • Shares Outstanding, K 1,068,273
  • Annual Sales, $ 56,630 K
  • Annual Income, $ 20,110 K
  • 60-Month Beta 0.18
  • Price/Sales 7.35
  • Price/Cash Flow 12.27
  • Price/Book 6.60
Trade ELTP with:
  • Price/Earnings ttm 38.98
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings $0.00 on 08/14/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1868 +107.44%
on 08/22/24
0.4199 -7.72%
on 09/12/24
+0.1885 (+94.72%)
since 08/16/24
3-Month
0.1625 +138.46%
on 06/21/24
0.4199 -7.72%
on 09/12/24
+0.2195 (+130.65%)
since 06/18/24
52-Week
0.0765 +406.54%
on 09/19/23
0.4199 -7.72%
on 09/12/24
+0.3056 (+373.14%)
since 09/18/23

Most Recent Stories

More News
Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium

Northvale, New Jersey--(Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information

Conference Call Scheduled for Thursday, August 15 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - August 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024

Financials for First Quarter of Fiscal Year 2025 Ended June 30, 2024 will be released on August 14, 2024Northvale, New Jersey--(Newsfile Corp. - August 9, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP)...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024

Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R)

NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022

Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer

NORTHVALE, NJ / ACCESSWIRE / May 11, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products,...

ELTP : 0.3875 (+1.31%)
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline

NORTHVALE, NJ / ACCESSWIRE / April 4, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that...

ELTP : 0.3875 (+1.31%)

Business Summary

Elite Pharmaceuticals, Inc. primarily engages in researching, developing, licensing, manufacturing, and marketing proprietary drug delivery systems and products. Their drug delivery technology involves releasing a drug into the bloodstream or delivering it to a target site in the body over an extended...

See More

Key Turning Points

3rd Resistance Point 0.4019
2nd Resistance Point 0.3970
1st Resistance Point 0.3922
Last Price 0.3875
1st Support Level 0.3825
2nd Support Level 0.3776
3rd Support Level 0.3728

See More

52-Week High 0.4199
Last Price 0.3875
Fibonacci 61.8% 0.2887
Fibonacci 50% 0.2482
Fibonacci 38.2% 0.2077
52-Week Low 0.0765

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar